FDA stem cell oversight at risk as clinics to ask SCOTUS to weigh in

FDA stem cell oversight

The U.S. Supreme Court could soon have a historic opportunity to limit the scope of FDA stem cell oversight. A large stem cell clinic firm now says it plans to ask SCOTUS to review a case it recently lost on appeal to the FDA. If SCOTUS takes the case, the FDA could find its powers […]

FDA stem cell oversight at risk as clinics to ask SCOTUS to weigh in Read More »

Georgia AG wins $5.1M judgment against stem cell clinic firm Superior Healthcare

STEVEN D. PEYROUX, Georgia stem cell clinic

The Georgia Attorney General has aggressively pursued stem cell clinic firms including one called Superior Healthcare. There is some more good news from Georgia. The FTC is involved too. Superior Healthcare, et al must pay $5.1 million Georgia AG Chris Carr has won more than $5.5 million in a judgment against this stem cell clinic

Georgia AG wins $5.1M judgment against stem cell clinic firm Superior Healthcare Read More »

Perspectives as Charles Brenner challenges David Sinclair on longevity claims

Charles Brenner, David Sinclair

Professor Charles Brenner of City of Hope does great research, but I also applaud his efforts against longevity hype. Recently, Brenner and James Timmons publicly questioned some of the work of Harvard Professor David Sinclair. It’s a notable case of academics intensely disagreeing in the public space. Background While it’s interesting, it’s also a somewhat

Perspectives as Charles Brenner challenges David Sinclair on longevity claims Read More »

Weekly reads: stem cell therapies that work, exosomes, H3.3 K27M, Joe Rogan

stem cell therapy

How close are we to having new stem cell therapies that work? The field is nearly there on several fronts, but we shouldn’t get ahead of ourselves. Last week I noted the “soon” in a Nature News headline “Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson’s disease could soon be here.”

Weekly reads: stem cell therapies that work, exosomes, H3.3 K27M, Joe Rogan Read More »

Grading my 20 stem cell & regenerative medicine predictions for 2024

Stem cell, crystal ball, predictions

Did you predict the major events in the stem cell and regenerative medicine field this year? I tried and today’s post are the grades on my predictions. Prediction is a key part of being a scientist even if we may not think about it that much. For instance, we have to try to predict what

Grading my 20 stem cell & regenerative medicine predictions for 2024 Read More »

Weekly reads: intermittent fasting and stem cells, vet warning, blastemas

intermittent fasting and stem cells

Intermittent fasting must be good for stem cells, right? It’s not so clear. Like many things in biology, intermittent fasting can have seemingly opposite effects. Before we get into that, the news of the week is that the FDA approved Mesoblast’s Ryoncil MSC drug for some cases of pediatric GvHD. This has sparked lively discussion.

Weekly reads: intermittent fasting and stem cells, vet warning, blastemas Read More »

In landmark, FDA approves first MSC therapy, Mesoblast’s Ryoncil for GvHD

mesoblast ceo dr silvio itescu

In a landmark decision, today the FDA approved Ryoncil from Mesoblast for GvHD. This is the first time the FDA has approved a mescenchymal stromal/stem cell or MSC therapy of any kind. There have been many ups and downs for Mesoblast toward this approval of Ryoncil or remestemcel-L, an allogeneic marrow MSC product. See my

In landmark, FDA approves first MSC therapy, Mesoblast’s Ryoncil for GvHD Read More »

Subscribe to Our Newsletter

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.